NCT02787902 is a NA clinical trial of Communication in Overweight or Obese, sponsored by University of California, San Diego.

Who is sponsoring NCT02787902?

NCT02787902 is sponsored by University of California, San Diego.

What drugs are being tested in NCT02787902?

Interventions in NCT02787902: Communication, Standard.

What condition does NCT02787902 study?

NCT02787902 studies Overweight or Obese.

Is NCT02787902 still recruiting?

NCT02787902 is currently completed. Last updated 12 October 2021.

Last reviewed 2021-10-12 · How we verify

NCT02787902

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Weight Management in Mothers and Adult Daughters

Completed NA Last updated 12 October 2021

What this trial tests

NA trial testing Communication in Overweight or Obese in 54 participants. Completed in 31 December 2020.

Timeline

1 August 2018

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	University of California, San Diego
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	54
Start date	1 August 2018
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across United States

Drugs / interventions tested

Communication
Standard

Conditions studied

Overweight or Obese — all drugs for Overweight or Obese →

Sponsor

University of California, San Diego

Who can join

Adults 18 to 65, female only, with Overweight or Obese. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop, implement, and evaluate a behavioral weight management intervention with a communication training component for Mexican-American women. The study has three specific aims. Aim 1: Develop a behavioral weight loss intervention that modifies evidence-based behavioral weight loss treatment using results from formative data collected from Mexican-American mother-daughter dyads. The adapted intervention will focus on improving dyadic communication and collaboration for providing reciprocal support for healthy eating and physical activity behaviors. Aim 2: Implement and evaluate a pilot weight management program adapted for mother-daughter dyads. Dyads will be randomly assigned to partner-based treatment with or without communication skills training. Aim 3: Evaluate associations between changes in weight, weight-related behaviors, and psychosocial variables with changes in measures assessing interpersonal communication.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Communication

Trials testing the same drug.

NCT07009886 — Development of an Educational Patient Decision Aid (Treatments in Advanced Cancer - Decision Aid, TA-DA) to Promote Shar · NA · recruiting
NCT04571658 — NEPTUNE Match Study · NA · recruiting
NCT06329934 — Refined Nursing in Rehabilitation Training · NA · completed
NCT04602351 — Communication in ICU During COVID-19 · completed

Other recruiting trials for Overweight or Obese

Currently open trials in the same condition.

NCT07514611 — Weight Loss Via Intelligent Guidance in Patients With Coronary Heart Disease and Obesity: a Randomized Clinical Trial · NA · recruiting
NCT07340125 — Pistachio Snacking and Metabolic Flexibility · NA · recruiting
NCT06859853 — A Study to Evaluate MWN109 Injection in Healthy Subjects · Phase 1 · recruiting
NCT07036601 — Phase II Study of THDBH120 Injection in Overweight or Obese Subjects · Phase 2 · recruiting
NCT06628362 — A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus · Phase 2 · active not recruiting

Other University of California, San Diego trials

Trials by the same sponsor.

NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02787902 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
Last refreshed: 12 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02787902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing